About «ADVANCED MEDICAL TECHNOLOGIES»
«ADVANCED MEDICAL TECHNOLOGIES» is an international team of professionals working in the field of Regenerative medicine and Stem Cell Therapy, created by people with professional experience in the field of health care. For more than 10 years, we have specialized in Stem Cell Therapy.
Stem Cell Therapy is an innovative and promising method of Regenerative medicine that allows restoring body functions lost due to diseases using Stem Cell transplantation.
Stem Cell transplantation is a technology that may be used for the treatment of various diseases which consists in conducting therapy using autologous (i.e. own) or allogeneic(i.e. donor) cell products derived from Multipotent Mesenchymal Stem Cells(MMSCs) isolated from various sources as well as Hematopoietic Cord Blood Cells (leukocyte cord blood fraction).
We work together with the leading world scientific and clinical centers to use the benefits of Regenerative medicine for a large number of serious diseases. Our specialists have developed unique and complex programs to help patients with disorders of the nervous system, the circulatory system, the musculoskeletal system and connective tissue, the digestive organs, the endocrine system, etc. They combine the use of Stem Cell technologies with other methods of treatment, which enhance the therapeutic effect of each other. (hyperbaric oxygen therapy, electrostimulation, physiotherapy, reflexotherapy, etc.)
We own GMP laboratories for isolating and cultivating Stem Cells as well as complexes of production facilities. We are the only holders of official permission for the manufacturing of Biomedical Cellular Products in Russia (License L0 48-00110-77/00609931 dated 19.08.2022.)
For more than 10 years, our clinics have been operating the largest banks for personal and public storage of Stem Cells and cord blood.
Therapy using Сord Blood Hematopoietic Cells (cord blood leukocyte fraction) received official approval from the Federal Service for Supervision of Healthcare of the Russian Federation FS No. 2009/387 from 11/23/2009) and for more than 10 years of experience has proven its effectiveness and safety.
We have developed and patented a unique method for isolating exosomes (regenerative substances) of multipotent mesenchymal Stem Cells. To date, using exosomes is the most promising direction in Regenerative medicine for regulating the functions of tissues and organs lost due to damage or disease.
Our clinics are members of the Scientific Association RUSCORD — an association of specialists and organizations in the field of procurement, storage, use of cord blood cells, and cell technologies.
We conduct our global clinical research on the use of cellular products to treat various diseases.